Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy

International Journal of Pharmaceutics

Volumn 320, Issue 1-2, 2006, Pages 96-103

  Le, Uyen M ^a   Cui, Zhengrong ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Distribution kinetics; NCT; Tumor size; Tumor type

Indexed keywords

GADOLINIUM; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG UPTAKE; ENCAPSULATION; FEMALE; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TISSUE DISTRIBUTION; TISSUE LEVEL; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; FEMALE; GADOLINIUM DTPA; LIPOSOMES; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEUTRON CAPTURE THERAPY; RADIOPHARMACEUTICALS; SARCOMA, EXPERIMENTAL; TIME FACTORS; TISSUE DISTRIBUTION; UTERINE CERVICAL NEOPLASMS;

EID: 33746385856     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.04.009     Document Type: Article

References (36)

1. Acker J.C., Dewhist M.W., Honore G.M., Samulski T.V., Tucker J.A., and Oleson J.R. Blood perfusion measurements in human tumours: evaluation of laser Doppler methods. Int. J. Hyperthermia 6 (1990) 287-304
2. Akine Y., Tokita N., Tokuuye K., Satoh M., Fukumori Y., Tokumitsu H., Kanamori R., Kobayashi T., and Kanda K. Neutron-capture therapy of murine ascites tumor with gadolinium-containing microcapsules. J. Cancer Res. Clin. Oncol. 119 (1992) 71-73
3. Barth R.F., Coderre J.A., Vicente M.G., and Blue T.E. Boron neutron capture therapy of cancer: current status and future prospects. Clin. Cancer Res. 11 (2005) 3987-4002
4. Barth R.F., and Soloway A.H. Perspective on boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 28 (1994) 1059-1060
5. Brugger R.M., and Shih J.A. Evaluation of gadolinium-157 as a neutron capture therapy agent. Strahlenther. Onkol. 165 (1989) 153-156
6. Caravan P., Ellison J.J., McMurry T.J., and Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99 (1999) 2293-2352
7. Carlsson J., Forssell-Aronsson E., and Glimelius B. Radiation therapy through activation of stable nuclides. Acta Oncol. 41 (2002) 629-634
8. Cui Z., and Huang L. Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer. Cancer Immunol. Immunother. 54 (2005) 1180-1190
9. Davies B., and Morris T. Physiological parameters in laboratory animals and humans. Pharm. Res. 10 (1993) 1093-1095
10. De Stasio G., Casalbore P., Pallini R., Gilbert B., Sanita F., Ciotti M.T., Rosi G., Festinesi A., Laorcca L.M., Rinelli A., Perret D., Mogk D.W., Perfetti P., Mehta M.P., and Mercanti D. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. Cancer Res. 61 (2001) 4272-4277
11. Dierling A.M., Sloat B.R., and Cui Z. Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapy. Eur. J. Pharm. Biopharm. 62 (2006) 275-281
12. Gabizon A., and Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6949-6953
13. Gabizon A.A. Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet. Clin. Cancer Res. 7 (2001) 223-225
14. Gillies R.J., Schornack P.A., Secomb T.W., and Raghunand N. Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1 (1999) 197-207
15. Harrington K.J., Mohammadtaghi S., Uster P.S., Glass D., Peters A.M., Vile R.G., and Stewart J.S. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res. 7 (2001) 243-254
16. Harrington K.J., Rowlinson-Busza G., Syrigos K.N., Abra R.M., Uster P.S., Peters A.M., and Stewart J.S. Influence of tumour size on uptake of (111)ln-DTPA-labelled pegylated liposomes in a human tumour xenograft model. Br. J. Cancer 83 (2000) 684-688
17. Hofmann B., Fischer C.O., Lawaczeck R., Platzek J., and Semmler W. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol. Invest. Radiol. 34 (1999) 126-133
18. Hwu P., Yang J.C., Cowherd R., Treisman J., Shafer G.E., Eshhar Z., and Rosenberg S.A. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res. 55 (1995) 3369-3373
19. Jono K., Ichikawa H., Fujioka K., Fukumori Y., Akine Y., and Tokuuye K. Preparation of lecithin microcapsules by a dilution method using the Wurster process for intraarterial administration in gadolinium neutron capture therapy. Chem. Pharm. Bull. 47 (1999) 54-63
20. Khokhlov V.F., Yashkin P.N., Silin D.I., Djorova E.S., and Lawaczeck R. Neutron capture therapy with gadopentetate dimeglumine: experiments on tumor-bearing rats. Acad. Radiol. 2 (1995) 392-398
21. Le U.M., and Cui Z. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy. Int. J. Pharm. 312 (2006) 105-112
22. Lin K.Y., Guarnieri F.G., Staveley-O'Carroll K.F., Levitsky H.I., August J.T., Pardoll D.M., and Wu T.C. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56 (1996) 21-26
23. Martin R.F., D'Cunha G., Pardee M., and Allen B.J. Induction of DNA double-strand breaks by 157Gd neutron capture. Pigment Cell Res. 2 (1989) 330-332
24. Massing U., and Fuxius S. Liposomal formulations of anticancer drugs: selectivity and effectiveness. Drug Resist. Updat. 3 (2000) 171-177
25. Matsumura A., Zhang T., Yamamoto T., Yoshida F., Sakurai Y., Shimojo N., and Nose T. In vivo gadolinium neutron capture therapy using a potentially effective compound (Gd-BOPTA). Anticancer Res. 23 (2003) 2451-2456
26. Miyamoto M., Hirano K., Ichikawa H., Fukumori Y., Akine Y., and Tokuuye K. Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron-capture therapy with tumor-bearing hamsters. Biol. Pharm. Bull. 22 (1999) 1331-1340
27. Miyamoto M., Ichikawa H., Fukumori Y., Akine Y., and Tokuuye K. Design and preparation of gadolinium-reservoir microcapsules for neutron-capture therapy by means of the Wurster process. Chem. Pharm. Bull. 45 (1997) 2043-2050
28. Oyewumi M.O., and Mumper R.J. Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles. Int. J. Pharm. (2003) 85-97
29. Oyewumi M.O., Yokel R.A., Jay M., Coakley T., and Mumper R.J. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J. Control. Release 95 (2004) 613-626
30. Sevick E.M., and Jain R.K. Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. Cancer Res. 49 (1989) 3506-3512
31. In: Shih J.L., and Brugger R.M. (Eds). Gadolinium as a neutron capture therapy agent. Med. Phys. 19 (1992) 733-744
32. Shikata F., Tokumitsu H., Ichikawa H., and Fukumori Y. In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur. J. Pharm. Biopharm. 53 (2002) 57-63
33. Su M.Y., Wang Z., Roth G.M., Lao X., Samoszuk M.K., and Nalcioglu O. Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn. Reson. Med. 36 (1996) 868-877
34. Tokumitsu H., Hiratsuka J., Sakurai Y., Kobayashi T., Ichikawa H., and Fukumori Y. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett. 150 (2000) 177-182
35. Tokumitsu H., Ichikawa H., and Fukumori Y. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm. Res. 16 (1999) 1830-1835
36. Watanabe T., Ichikawa H., and Fukumori Y. Tumor accumulation of gadolinium in lipid-nanoparticles intravenously injected for neutron-capture therapy of cancer. Eur. J. Pharm. Biopharm. 54 (2002) 119-124